Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Mild Cognitive Impairment (MCI)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Pravat Mandal) · mandalpk@pitt.edu · 4126999561
Contact: Study coordinator (Nazia Pillar) · clinic55@pitt.edu
Riddhi Patira, MD (Sub-investigator)

Study leads

Pravat Mandal, PhD
Principal Investigator
University of Pittsburgh

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

Alzheimer Disease · Mild Cognitive Impairment · Logopenic Progressive Aphasia

Abroad (travel likely)RecruitingEARLY_PHASE1

Boston, United States

MCI Speech in Noise

Mild Cognitive Impairment

Abroad (travel likely)Recruiting

Lebanon, United States

Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States

Music for Pain and Dementia

Alzheimer Disease · Dementia · Mild Cognitive Impairment

Abroad (travel likely)Recruiting

New Haven, United States